| Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
|---|---|---|---|---|---|---|
| [glucose-6-phosphate isomerase]-N6-succinyl-L-lysine + NAD+ + H2O | Homo sapiens | - |
[glucose-6-phosphate isomerase]-L-lysine + 2''-O-succinyl-ADP-D-ribose + nicotinamide | - |
? | |
| [glucose-6-phosphate isomerase]-N6-succinyl-L-lysine + NAD+ + H2O | Mus musculus | - |
[glucose-6-phosphate isomerase]-L-lysine + 2''-O-succinyl-ADP-D-ribose + nicotinamide | - |
? |
| Organism | UniProt | Comment | Textmining |
|---|---|---|---|
| Homo sapiens | Q9NXA8 | - |
- |
| Mus musculus | Q8K2C6 | - |
- |
| Source Tissue | Comment | Organism | Textmining |
|---|---|---|---|
| natural killer cell line | - |
Homo sapiens | - |
| natural killer cell line | - |
Mus musculus | - |
| Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
|---|---|---|---|---|---|---|
| [glucose-6-phosphate isomerase]-N6-succinyl-L-lysine + NAD+ + H2O | - |
Homo sapiens | [glucose-6-phosphate isomerase]-L-lysine + 2''-O-succinyl-ADP-D-ribose + nicotinamide | - |
? | |
| [glucose-6-phosphate isomerase]-N6-succinyl-L-lysine + NAD+ + H2O | - |
Mus musculus | [glucose-6-phosphate isomerase]-L-lysine + 2''-O-succinyl-ADP-D-ribose + nicotinamide | - |
? |
| Synonyms | Comment | Organism |
|---|---|---|
| SIRT5 | - |
Homo sapiens |
| SIRT5 | - |
Mus musculus |
| Organism | Comment | Expression |
|---|---|---|
| Homo sapiens | downregulated in the extranodal natural killer/T-cell lymphoma | down |
| Mus musculus | downregulated in the extranodal natural killer/T-cell lymphoma | down |
| General Information | Comment | Organism |
|---|---|---|
| drug target | SIRT5 inhibits glycolysis via catalyzing the desuccinylation of glycolytic enzyme glucose-6-phosphate isomerase, thereby repressing extranodal natural killer/T-cell lymphoma, nasal type (ENKTL) cell proliferation and tumor growth. As SIRT5 serves as a tumor suppressor in ENKTL, it may be a promising molecular target in therapy strategy | Homo sapiens |
| physiological function | SIRT5 inhibits glycolysis via catalyzing the desuccinylation of glycolytic enzyme glucose-6-phosphate isomerase, thereby repressing extranodal natural killer/T-cell lymphoma, nasal type (ENKTL) cell proliferation and tumor growth. As SIRT5 serves as a tumor suppressor in ENKTL, it may be a promising molecular target in therapy strategy | Homo sapiens |
| physiological function | SIRT5 inhibits glycolysis via catalyzing the desuccinylation of glycolytic enzyme glucose-6-phosphate isomerase, thereby repressing extranodal natural killer/T-cell lymphoma, nasal type (ENKTL) cell proliferation and tumor growth. As SIRT5 serves as a tumor suppressor in ENKTL, it may be a promising molecular target in therapy strategy | Mus musculus |